Details of Drug-Metabolizing Enzyme (DME)
| General Information of DME (ID: DME1666) | |||||
|---|---|---|---|---|---|
| DME Name | Unclear metabolic mechanism (DME-unclear), Bifidobacterium catenulatum | ||||
| Gene Name | DME-unclear | ||||
| Lineage | Species: Bifidobacterium catenulatum (Click to Show/Hide the Complete Species Lineage) | ||||
| Click to Show/Hide the Molecular/Functional Data (Sequence/Structure/Pathway/Function) of This DME | |||||
| Tissue Distribution | Primarily distributed in human gut. | ||||
| Full List of Drug(s) Metabolized by This DME | |||||
|---|---|---|---|---|---|
| Preclinical/investigative Agents | Click to Show/Hide the Full List of Drugs: 1 Drugs | ||||
Secoisolariciresinol |
Drug Info | Investigative | Diabetes mellitus | ICD11: 5A10 | [1] |
| References | |||||
|---|---|---|---|---|---|
| 1 | Influence of different lignan compounds on enterolignan production by Bifidobacterium and Lactobacillus strains. Int J Food Microbiol. 2019 Jan 16;289:17-23. | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.